Windlas Biotech
Company Overview - January 14, 2025
Windlas Biotech is a notable player in the Pharmaceuticals - Indian - Formulations industry, listed on both the BSE (Code: 543329) and NSE (Code: WINDLAS). As of the January 14, 2025, the company holds a market capitalization of INR 2296.93 crores, placing it among the top-performing companies in its sector.
With a current stock price of INR 1099.00, Windlas Biotech has demonstrated a 147.95% return over the last year. Recent performance indicates fluctuations, with a 8.51% change in the past week and a 2.69% change over the last month. The company's all-time high stands at INR 1198.25, while its lowest-ever price was INR 203.15.
In terms of sales, Windlas Biotech reported a revenue of INR 695.65 crores, solidifying its position in the market. The average trading volume over the past month has been 85786 shares, with a more recent weekly average of 99459.
With the stock trading above its 50-day moving average of INR 965.81, the company's technical indicators like MACD (10.49) signal negative trends.
Company Data
| Name | Windlas Biotech |
|---|---|
| BSE Code | 543329 |
| NSE Code | WINDLAS |
| Industry | Pharmaceuticals - Indian - Formulations |
| Current Price | 1099.00 |
| Market Capitalization | 2296.93 |
| Sales | 695.65 |
| Return over 3months | 27.29 |
| Return over 6months | 65.08 |
| Volume 1month average | 85786 |
| Volume 1week average | 99459 |
| Volume | 45231 |
| High price | 1198.25 |
| Low price | 397.90 |
| High price all time | 1198.25 |
| Low price all time | 203.15 |
| Return over 1day | 5.44 |
| Return over 1week | 8.51 |
| Return over 1month | 2.69 |
| Return over 1year | 147.95 |
| Return over 3years | 54.45 |
| Return over 5years | |
| Volume 1year average | 121970 |
| DMA 50 | 965.81 |
| DMA 200 | 764.82 |
| DMA 50 previous day | 962.64 |
| DMA 200 previous day | 762.01 |
| MACD | 10.49 |
| MACD Signal | 13.46 |